Adiponectin induces oncostatin M expression in osteoblasts through the PI3K/Akt signaling pathway

12Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Rheumatoid arthritis (RA), a common autoimmune disorder, is associated with a chronic inflammatory response and unbalanced bone metabolism within the articular microenvironment. Adiponectin, an adipokine secreted by adipocytes, is involved in multiple functions, including lipid metabolism and pro-inflammatory activity. However, the mechanism of adiponectin performance within arthritic inflammation remains unclear. In this study, we observed the effect of adiponectin on the expression of oncostatin M (OSM), a pro-inflammatory cytokine, in human osteoblastic cells. Pretreatment of cells with inhibitors of phosphatidylinositol 3-kinase (PI3K), Akt, and nuclear factor (NF)-κB reduced the adiponectin-induced OSM expression in osteoblasts. Stimulation of the cells with adiponectin increased phosphorylation of PI3K, Akt, and p65. Adiponectin treatment of osteoblasts increased OSM-luciferase activity and p65 binding to NF-κB on the OSM promoter. Our results indicate that adiponectin increased OSM expression via the PI3K, Akt, and NF-κB signaling pathways in osteoblastic cells, suggesting that adiponectin is a novel target for arthritis treatment.

Cite

CITATION STYLE

APA

Su, C. M., Lee, W. L., Hsu, C. J., Lu, T. T., Wang, L. H., Xu, G. H., & Tang, C. H. (2015). Adiponectin induces oncostatin M expression in osteoblasts through the PI3K/Akt signaling pathway. International Journal of Molecular Sciences, 17(1). https://doi.org/10.3390/ijms17010029

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free